Stifel maintains Buy rating on Freshpet stock despite lowered 2025 revenue guidance

Published 05/08/2025, 17:30
Stifel maintains Buy rating on Freshpet stock despite lowered 2025 revenue guidance

Investing.com - Stifel has reiterated its Buy rating and $90.00 price target on Freshpet (NASDAQ:FRPT) following the company’s second-quarter earnings report that showed stronger-than-expected EBITDA despite softer sales growth. The company, currently valued at $3.37 billion, has generated $138 million in EBITDA over the last twelve months. According to InvestingPro analysis, Freshpet appears undervalued at current levels.

The pet food company reported second-quarter results with EBITDA exceeding expectations, driven by stronger margin expansion that more than offset weaker sales growth performance.

Freshpet lowered its 2025 revenue guidance while maintaining its EBITDA outlook, with the sustained EBITDA projection supported by stronger margin expansion that compensates for the sales slowdown.

Stifel’s 2025-2027 sales and adjusted EBITDA estimates remain largely unchanged following the second-quarter results, with the firm viewing Freshpet’s updated 2027 targets as encouraging despite the sales slowdown.

The research firm noted that while it maintains its Buy rating and $90 target price, Freshpet shares could remain range-bound in the near term until the company demonstrates a reacceleration in sales trends and household penetration.

In other recent news, Freshpet reported its second-quarter 2025 earnings, delivering a notable earnings-per-share (EPS) of $0.33. This figure significantly surpassed analyst expectations of $0.11, representing a 200% surprise. However, the company slightly missed revenue projections despite the impressive EPS results. In analyst coverage, UBS reiterated its Sell rating on Freshpet, maintaining a price target of $65.00. The investment bank expressed concerns over Freshpet’s top-line growth potential, though it acknowledged the company’s flexibility regarding profitability targets. These developments highlight the mixed sentiment surrounding Freshpet’s financial health and future growth prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.